Your browser doesn't support javascript.
loading
Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study).
Wedner, H James; Fujisawa, Takao; Guilbert, Theresa W; Ikeda, Masanori; Mehta, Vinay; Tam, Jonathan S; Lukka, Pradeep B; Asimus, Sara; Durzynski, Tomasz; Johnston, James; White, Wendy I; Shah, Mihir; Werkström, Viktoria; Jison, Maria L.
Afiliación
  • Wedner HJ; Division of Allergy and Immunology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Fujisawa T; Allergy Center, National Hospital Organization Mie National Hospital, Tsu, Japan.
  • Guilbert TW; Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Ikeda M; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Mehta V; Okayama University School of Medicine, Okayama, Japan.
  • Tam JS; Department of Pediatrics, Fukuyama Municipal Hospital, Fukuyama, Hiroshima, Japan.
  • Lukka PB; Allergy, Asthma and Immunology Associates, Lincoln, Nebraska, USA.
  • Asimus S; Division of Clinical Immunology and Allergy, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Durzynski T; Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Johnston J; Clinical Pharmacology & Quantitative Pharmacology, R&D, AstraZeneca, Gothenburg, Sweden.
  • White WI; Late R&I Clinical Development, BioPharmaceuticals R&D, AstraZeneca, Warsaw, Poland.
  • Shah M; Biostatistics, R&I Biologics and Vaccine Products, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Werkström V; Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Jison ML; Late R&I Clinical Development, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
Pediatr Allergy Immunol ; 35(3): e14092, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38491795
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Asma / Antiasmáticos / Anticuerpos Monoclonales Humanizados Límite: Adolescent / Adult / Child / Humans Idioma: En Revista: Pediatr Allergy Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / PEDIATRIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Asma / Antiasmáticos / Anticuerpos Monoclonales Humanizados Límite: Adolescent / Adult / Child / Humans Idioma: En Revista: Pediatr Allergy Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / PEDIATRIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos